Benefits and Risks of Periconceptional Folic Acid Supplementation-Reply
JAMA Neurol
.
2023 Apr 1;80(4):421-422.
doi: 10.1001/jamaneurol.2023.0092.
Authors
Håkon Magne Vegrim
1
,
Torbjörn Tomson
2
,
Marte-Helene Bjørk
1
3
4
Affiliations
1
Department of Clinical Medicine, University of Bergen, Bergen, Norway.
2
Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
3
Department of Neurology, Haukeland University Hospital, Bergen, Norway.
4
Department of Clinical Neurophysiology, Haukeland University Hospital, Bergen, Norway.
PMID:
36877510
DOI:
10.1001/jamaneurol.2023.0092
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Letter
Comment
MeSH terms
Dietary Supplements*
Folic Acid* / adverse effects
Humans
Risk Assessment
Substances
Folic Acid